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Machine perfusion is rapidly becoming the standard for graft preservation and provide new 
opportunities for organ salvage, reconditioning and repair. Based on their immune modulatory 
and regenerate properties,1 arguable mesenchymal stromal cells (MSCs) are the most promising 
cell therapy for graft repair “on the pump”, though proof of concept is still lacking.2 Here we 
show the feasibility of delivering clinically relevant numbers of human MSCs (hMSC; 5-
10x106/kg) during 30 min hypothermic oxygenated machine perfusion (HOPE) in porcine liver 
grafts (n=8)(Figure 1). Full methods are described in Supplemental Materials and Methods 
(SDC, http://links.lww.com/TP/B821). To track the biodistribution of hMSC, cells were 
genetically labeled with click beetle red luciferase (CBred2).3 As shown in Figure 2, 
bioluminescent imaging of both the anterior and posterior side of the liver showed a wide range 
and patchy distribution of hMSC which retain throughout the liver after 30 minutes of perfusion. 
No significant difference between arterial (n=4) or venous infusion (n=4) was observed. 
Histological and RNA-expression analysis confirmed the delivery of the hMSC throughout the 
liver grafts. About 104-105 hMSC were estimated to be still present per kg liver graft. 
Importantly, the hMSC retained their paracrine activity after infusion. Using both Luminex and 
LC-MS/MS analysis, increasing levels of human-specific IL-6 and IL-8 released in porcine 
blood were shown during 4 hour normothermic perfusion. In conclusion, this is the first report 
showing effective delivery of hMSC in a liver machine perfusion model. Evidence of paracrine 
activity of hMSC after delivery indicate regenerative and immune modulatory effects during 
normothermic graft perfusion, though this needs further research in a transplantation model. 
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Figure Legends 
Figure 1. Graphical abstract of the procedure. 
The time line indicates the details of each time point. Pig livers are procured after a warm 
ischemia period of 30 min and infused with 5x106 - 107 CBred2-labeled hMSC either via the 
portal vein or hepatic artery. The distribution of hMSC is visualized by bioluminescence imaging 
(BLI) immediately (time point 0) after infusion using an IVIS Imaging System 200. The liver is 
then placed on a purpose-made perfusion device in which it is perfused with cold (10˚C) 
oxygenated UW-organ preservation fluid. After 30 min of perfusion, the distribution of the 
hMSC is again imaged using BLI. After imaging, the livers were perfused for 4 hours with their 
own, heparinized, full blood at normothermic temperature (37˚C) by ex vivo machine perfusion 
after which biopsies were collected for further analysis. The BLI signal is quantified, presence of 
hMSC was assessed in biopsies taken from left and right periphery and center of the liver using 
human-specific antibodies, proteomic and genetic analysis. 
Figure 2. Effective delivery of paracrine active hMSCs during normothermic hepatic 
machine perfusion. Live imaging of the livers (n=8) infused with CBred2-transduced hMSC in 
the hepatic artery (n=4, A, B, E, F) or portal vein (n=4, C, D, G, H) using the IVIS Imaging 
System 200, directly after infusion (directly after infusion, A, B, C, D) and after 30 min of 
perfusion (E, F, G, H). Images are representative images showing bright luciferin-based 
luminescence at the posterior (A, C, E, G) and anterior side (B, D, F, H) of the liver, 
demonstrating whole organ coverage of the infused hMSC. The presence of hMSC was 
confirmed by immunohistochemical staining for copGFP (I arrows; 40x objective) at end of 
perfusion whereas no staining was observed in liver biopsies prior to infusion (J). Representative 
pictures are shown. Human-specific B2M gene expression was determined by nested qPCR to 
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confirm the presence of human MSC in the pig liver at the genetic level (M). Shown are the raw 
Ct-values of B2M expression of three pigs. B2M expression was measured in the pig samples 
that were perfused with hMSC, (pig 1-3) and in nonperfused pig livers (n=3). nd: not detectable. 
Luminex-based analysis using human specific cytokines showed that IL-6 (O) and IL-8 (P) was 
secreted in the liver perfusate in 2 of the 4 pigs that were infused via the hepatic artery (filled 
symbols). In pig livers that were not infused with hMSC no IL-6 or IL-8 was detected (open 
symbols).  Human-specific IL-6 and IL-8 protein release was confirmed in the same two pig 
livers by LC/MS analysis (data not shown). 
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Figure 2 
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